Athens, GA, United States of America

Russell K Karls

This inventor holds 2 USPTO granted patents. Top assignee: University of Georgia Research Foundation Inc. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell K Karls. Retrieved from https://idiyas.com/inventor/russell-k-karls

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Russell K. Karls

Introduction

Russell K. Karls is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of microbial vaccines, holding a total of 2 patents. His work focuses on developing innovative solutions to enhance vaccine efficacy and delivery.

Latest Patents

One of his latest patents is centered around a microbial vaccine and vaccine vector. This invention includes a cold-adapted, acid-fast bacterium designed for use as a vaccine and a vaccine vector. In preferred embodiments, the cold-adapted, acid-fast bacterium serves as a crucial component in advancing vaccine technology.

Career Highlights

Russell K. Karls is affiliated with the University of Georgia Research Foundation, Inc., where he conducts his research and development activities. His work has been instrumental in pushing the boundaries of vaccine research, contributing to public health advancements.

Collaborations

He has collaborated with notable colleagues such as Frederick Quinn and Candace McCombs, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Russell K. Karls continues to be a driving force in the field of microbial vaccines, with his innovative patents paving the way for future advancements in vaccine technology. His contributions are vital to improving health outcomes and addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…